These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17229018

  • 21. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
    Ringe JD, Reginster JY, Gennari C, Hosking DJ, Meunier PJ.
    Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
    [Abstract] [Full Text] [Related]

  • 22. Bisphosphonate use in the treatment of Paget's disease of the bone: analysis of claims in a large database.
    Dolgitser M, Stern L, Katz LM, Doyle JJ, Omar M, Seton M, Kahler KH.
    Manag Care Interface; 2007 Feb; 20(2):33-40. PubMed ID: 17405580
    [Abstract] [Full Text] [Related]

  • 23. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.
    Cremers SC, Eekhoff ME, Den Hartigh J, Hamdy NA, Vermeij P, Papapoulos SE.
    J Bone Miner Res; 2003 May; 18(5):868-75. PubMed ID: 12733726
    [Abstract] [Full Text] [Related]

  • 24. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
    Kraj M, Pogłód R, Maj S, Pawlikowski J, Sokołowska U, Szczepanik J.
    Acta Pol Pharm; 2002 May; 59(6):478-82. PubMed ID: 12669777
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic management of Paget's disease.
    Stumpf JL.
    Clin Pharm; 1989 Jul; 8(7):485-95. PubMed ID: 2666012
    [Abstract] [Full Text] [Related]

  • 26. Risedronate: a new oral bisphosphonate.
    Umland EM, Boyce EG.
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [Abstract] [Full Text] [Related]

  • 27. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM, Au-Yeong ML, McKenna MJ.
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [Abstract] [Full Text] [Related]

  • 28. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Oct; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 30. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
    Tucci JR, Bontha S.
    Endocr Pract; 2001 Oct; 7(6):423-9. PubMed ID: 11747277
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY, Lecart MP.
    Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ, Gunasekera RD.
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Current options for the treatment of Paget's disease of bone].
    Audran M.
    Presse Med; 1996 Oct 05; 25(29):1317-9. PubMed ID: 8966189
    [Abstract] [Full Text] [Related]

  • 39. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Oct 05; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

  • 40. Drug treatment strategies for paget's disease: relieving pain and preventing progression.
    Merlotti D, Rendina D, Cavati G, Abate V, Falchetti A, Mingiano C, Nuti R, Gennari L.
    Expert Opin Pharmacother; 2023 Apr 05; 24(6):715-727. PubMed ID: 36961938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.